These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24008548)

  • 1. Clinical characteristics and risk factors for infantile hemangioma--a case control study.
    Rasul S
    Eur J Pediatr Surg; 2014 Feb; 24(1):102-12. PubMed ID: 24008548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic and clinical characteristics and risk factors for infantile hemangioma: a Chinese case-control study.
    Li J; Chen X; Zhao S; Hu X; Chen C; Ouyang F; Liu Q; Ding R; Shi Q; Su J; Kuang Y; Chang J; Li F; Xie H
    Arch Dermatol; 2011 Sep; 147(9):1049-56. PubMed ID: 21576550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of propranolol for treatment of hemangiomas in PHACE syndrome.
    Solomon T; Ninnis J; Deming D; Merritt TA; Hopper A
    J Perinatol; 2011 Nov; 31(11):739-41. PubMed ID: 22037156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol in the management of airway infantile hemangiomas.
    Rosbe KW; Suh KY; Meyer AK; Maguiness SM; Frieden IJ
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):658-65. PubMed ID: 20644059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth characteristics of infantile hemangiomas: implications for management.
    Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
    Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Facial hemangioma associated with arterial anomalies, coarctation of the aorta, and eye abnormalities: PHACES syndrome].
    Buzenet C; Hamel-Teillac D; Acar P; Becquet F; Curan D; Michaud V; Sidi D; De Prost Y
    Ann Dermatol Venereol; 2000 Mar; 127(3):292-5. PubMed ID: 10804305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile hemangiomas and retinopathy of prematurity: possible association.
    Praveen V; Vidavalur R; Rosenkrantz TS; Hussain N
    Pediatrics; 2009 Mar; 123(3):e484-9. PubMed ID: 19221153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional steroids in cutaneous hemangioma.
    Reyes BA; Vazquez-Botet M; Capo H
    J Dermatol Surg Oncol; 1989 Aug; 15(8):828-32. PubMed ID: 2754087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas.
    Haggstrom AN; Skillman S; Garzon MC; Drolet BA; Holland K; Matt B; McCuaig C; Metry DW; Morel K; Powell J; Frieden IJ
    Arch Otolaryngol Head Neck Surg; 2011 Jul; 137(7):680-7. PubMed ID: 21768412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subglottic hemangioma: Understanding the association with facial segmental hemangioma in a beard distribution.
    McCormick AA; Tarchichi T; Azbell C; Grunwaldt L; Jabbour N
    Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():34-37. PubMed ID: 30174006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile hemangiomas with minimal or arrested growth: a retrospective case series.
    Suh KY; Frieden IJ
    Arch Dermatol; 2010 Sep; 146(9):971-6. PubMed ID: 20855695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of systemic corticosteroids in management of a large congenital haemangioma of the scalp.
    Hackett BC; Phelan E; Ryan A; Kenny L; Murphy M; Irvine AD; Watson RM
    Pediatr Dermatol; 2013; 30(6):e121-4. PubMed ID: 23004357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHACES syndrome: otolaryngic considerations in recognition and management.
    Rudnick EF; Chen EY; Manning SC; Perkins JA
    Int J Pediatr Otorhinolaryngol; 2009 Feb; 73(2):281-8. PubMed ID: 19081148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Clinical Properties and Treatment Responses of Infantile Hemangioma.
    Yildirimcakar D; Demirsoy U; Azizoglu M; Corapcioglu F
    J Drugs Dermatol; 2020 Dec; 19(12):1156-1165. PubMed ID: 33346523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of infantile hemangiomas.
    Püttgen KB
    Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infantile hepatic hemangiomas: first-line propranolol monotherapy as new treatment strategy?].
    Baranowski S; Winkler A; Kunzi-Rapp K; Schaal M; Hempel S; Debatin KM; Posovszky C
    Klin Padiatr; 2012 Oct; 224(6):393-5. PubMed ID: 23143767
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development.
    Haggstrom AN; Lammer EJ; Schneider RA; Marcucio R; Frieden IJ
    Pediatrics; 2006 Mar; 117(3):698-703. PubMed ID: 16510649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas.
    Krol A; MacArthur CJ
    Arch Facial Plast Surg; 2005; 7(5):307-11. PubMed ID: 16172338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.